首页> 外国专利> THERAPEUTIC AGENT FOR SEQUELAE OF CEREBROVASCULAR DISORDER OR CEREBRAL NERVE DISORDER AFTER CEREBRAL ISCHEMIA

THERAPEUTIC AGENT FOR SEQUELAE OF CEREBROVASCULAR DISORDER OR CEREBRAL NERVE DISORDER AFTER CEREBRAL ISCHEMIA

机译:脑缺血后继发性脑血管疾病或脑神经疾病的治疗剂

摘要

PROBLEM TO BE SOLVED: To obtain a therapeutic agent effective for treating and preventing sequelae of cerebrovascular disorder such as cerebral vascular dementia and cerebral nerve disorder after cerebral ischemia, containing a non-steroid antiinflammatory compound. ;SOLUTION: This therapeutic agent comprises a non-steroid antiinflammatory compound such as an acidic non steroid antiinflammatory compound such as an alkanolcarboxylic acid-based antiinflammatory compound such as an arylpropionic acid-based compound such as ketoprofen and is optionally used together with a cerebral metabolism, a cerebral edema inhibitor, a psychotropic medicine, an antihypertensive agent, a therapeutic agent for hyperlipemia, an antithrombotic medicine, etc.;COPYRIGHT: (C)1998,JPO
机译:要解决的问题:包含非甾体抗炎化合物的治疗剂,该治疗剂可有效治疗和预防脑缺血后脑血管疾病如脑血管性痴呆和脑神经疾病的后遗症。 ;解决方案:该治疗剂包含非甾体类抗炎化合物,例如酸性非甾体类抗炎化合物,例如链烷醇羧酸类抗炎化合物,例如芳丙酸类化合物(例如酮洛芬),并且可与脑代谢一起使用,脑水肿抑制剂,精神药物,抗高血压药,高脂血症治疗药,抗血栓药等;版权所有:(C)1998,日本特许厅

著录项

  • 公开/公告号JPH107590A

    专利类型

  • 公开/公告日1998-01-13

    原文格式PDF

  • 申请/专利权人 CHUGAI PHARMACEUT CO LTD;

    申请/专利号JP19960198246

  • 发明设计人 OGAWA NORIO;ASANUMA MIKITO;

    申请日1996-06-24

  • 分类号A61K45/00;A61K31/19;

  • 国家 JP

  • 入库时间 2022-08-22 03:02:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号